Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 29, 2025	Jun. 30, 2024
CASH FLOWS (USED FOR)/PROVIDED BY OPERATING ACTIVITIES:
Net loss	$ (474,523)	$ (11,594)
Adjustments to reconcile net loss to net cash (used for)/provided by operating activities:
Depreciation and amortization expense	69,683	68,186
Deferred and other income taxes	(30,785)	(5,338)
Goodwill impairment	355,958	0
Other asset impairments and lease termination charges	51,136	448
Loss/(gain) on disposal of property and equipment	403	(3)
Loss on divestiture of Insomnia Cookies	11,501	0
Gain on sale-leaseback	(6,749)	0
Share-based compensation	7,237	14,634
Change in accounts and notes receivable allowances	986	327
Inventory write-off	1,495	1,038
Amortization related to settlement of interest rate swap derivatives	0	(5,910)
Other	2,224	858
Change in operating assets and liabilities, excluding foreign currency translation adjustments	(41,943)	(47,121)
Net cash (used for)/provided by operating activities	(53,377)	15,525
CASH FLOWS PROVIDED BY/(USED FOR) INVESTING ACTIVITIES:
Purchase of property and equipment	(54,106)	(60,735)
Proceeds from sale-leaseback	10,882	0
Purchase of equity method investment	(2,140)	(3,506)
Net proceeds from divestiture of Insomnia Cookies	75,000	0
Principal payments received from loans to franchisees	1,202	0
Disbursement for loan receivable	0	(1,086)
Other investing activities	99	166
Net cash provided by/(used for) investing activities	30,937	(65,161)
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:
Proceeds from the issuance of debt	516,900	365,000
Repayment of long-term debt and lease obligations	(485,894)	(306,797)
Payment of financing costs	(825)	0
Proceeds from structured payables	198,052	190,162
Payments on structured payables	(199,228)	(190,811)
Capital contribution by shareholders, net of loans issued	0	919
Distribution to shareholders	(11,934)	(11,807)
Payments for repurchase and retirement of common stock	(787)	(4,275)
Distribution to noncontrolling interest	(36)	(2,146)
Net cash provided by financing activities	16,248	40,245
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,300)	(115)
Net decrease in cash, cash equivalents and restricted cash	(7,492)	(9,506)
Cash, cash equivalents and restricted cash at beginning of period	29,315	38,614
Cash, cash equivalents and restricted cash at end of period	21,823	29,108
Supplemental schedule of non-cash investing and financing activities:
Increase in accrual for property and equipment	10,312	12,176
Accrual for distribution to shareholders	0	(5,919)
Reconciliation of cash, cash equivalents and restricted cash at end of period:
Cash and cash equivalents	21,264	28,625
Restricted cash	559	483
Total cash, cash equivalents and restricted cash	$ 21,823	$ 29,108